Dr. Marc C. Gittelman

Marc C. Gittelman

MD, FACS
Urologist
Languages Spoken:
English
Request an appointment For Providers

Overview

Career positions

  • URO-Care, URO-MEDIX - Founder, Co-Medical Director and Urologist, Miami, FL
  • South Florida Medical Research - Executive Director and CEO, Aventura, FL
  • University of Miami - Assistant Professor of Medicine, Miami, FL

Education

Universities

  • Tufts University, BS, Biology, Medford, MA
  • Mount Sinai School of Medicine, New York, NY

Internship

  • Mount Sinai Medical Center, General Surgery, New York, NY

Residency

  • Mount Sinai Medical Center, Urology, Chief Resident, New York, NY

Expertise and interests

  • Benign Prostatic Hyperplasia (BPH)
  • Prostate Health
  • Prostate Cancer
  • Sexual Health for Men
  • Erectile Dysfunction
  • Low Testosterone
  • Sexual Health issues for Women
  • Kidney Stones
  • Urinary Tract Infections
  • Voiding and Leakage Problems

Professional association

Awards and honors

  • Phi Beta Kappa and summa cum laude at Tufts University
  • Alpha Omega Alpha Medical Honor Society
  • Sigma Xi Research Society
  • Anna Quincy Churchill Prize for General Biology

Publications

  • A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men.
  • Convective Thermal Therapy: Durable 2-Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
  • Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study
  • Response and Rebuttal to Editorial Commentary on "Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study"
  • A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men
  • An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implanted Nitinol Device. View publication

How can we help?

Our staff will provide answers to your questions within 24 hours. Otherwise, if you have a medical emergency please call 911.

*Indicates a required field

By submitting you are confirming that you have read the SunState Medical Specialists Website Terms of Use.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.